US Stock MarketDetailed Quotes

OVID Ovid Therapeutics

Watchlist
  • 1.150
  • +0.020+1.77%
Close Oct 4 16:00 ET
  • 1.150
  • 0.0000.00%
Post 16:02 ET
81.62MMarket Cap-2804P/E (TTM)

Ovid Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
125.33%169K
124.24%148K
-73.93%391.7K
205.88%141.56K
881.55%108.97K
75K
-95.43%66K
-99.28%1.5M
46.28K
11.1K
Operating revenue
125.33%169K
124.24%148K
-73.93%391.7K
205.88%141.56K
881.55%108.97K
--75K
-95.43%66K
-99.28%1.5M
--46.28K
--11.1K
Cost of revenue
Gross profit
Operating expense
45.20%20.69M
17.43%17.57M
4.60%59.67M
50.02%18.33M
-5.29%12.14M
-0.40%14.25M
-15.55%14.96M
-32.22%57.05M
-53.63%12.22M
9.71%12.82M
Selling and administrative expenses
-1.75%8.1M
-14.08%7.17M
-4.15%31.09M
15.40%7.69M
-10.84%6.81M
-0.11%8.25M
-15.56%8.34M
-12.89%32.43M
-19.36%6.66M
12.83%7.63M
-General and administrative expense
-1.75%8.1M
-14.08%7.17M
-4.15%31.09M
15.40%7.69M
-10.84%6.81M
-0.11%8.25M
-15.56%8.34M
-12.89%32.43M
-19.36%6.66M
12.83%7.63M
Research and development costs
109.73%12.58M
57.17%10.4M
16.12%28.59M
91.53%10.64M
2.88%5.33M
-0.79%6M
-15.54%6.62M
-47.55%24.62M
-69.29%5.56M
5.41%5.18M
Operating profit
-44.77%-20.52M
-16.96%-17.42M
-6.72%-59.28M
-49.42%-18.19M
6.06%-12.03M
0.92%-14.17M
8.45%-14.89M
-144.72%-55.55M
53.81%-12.17M
-9.61%-12.8M
Net non-operating interest income expense
4.9M
Non-operating interest income
----
----
--4.9M
----
----
----
----
----
----
----
Other net income (expense)
1,546.15%29.04M
272.59%5.72M
45.02%2M
-410.75%-2.08M
-7.13%776.45K
720.85%1.76M
634.75%1.54M
3,118.45%1.38M
17,018.19%668.12K
31,367.26%836.09K
Gain on sale of security
----
----
--2M
----
----
----
----
----
----
----
Other non- operating income (expenses)
1,546.15%29.04M
272.59%5.72M
----
----
-7.13%776.45K
720.85%1.76M
634.75%1.54M
3,118.45%1.38M
17,018.19%668.12K
31,367.26%836.09K
Income before tax
168.67%8.52M
12.44%-11.69M
3.38%-52.34M
-33.18%-15.32M
5.98%-11.25M
14.95%-12.41M
16.83%-13.36M
-143.63%-54.17M
56.34%-11.5M
-2.47%-11.97M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
168.67%8.52M
12.44%-11.69M
3.38%-52.34M
-33.18%-15.32M
5.98%-11.25M
14.95%-12.41M
17.08%-13.36M
-144.10%-54.17M
55.75%-11.5M
-5.13%-11.97M
Net income continuous Operations
168.67%8.52M
12.44%-11.69M
3.38%-52.34M
-33.18%-15.32M
5.98%-11.25M
14.95%-12.41M
17.08%-13.36M
-144.10%-54.17M
55.75%-11.5M
-5.13%-11.97M
Minority interest income
Net income attributable to the parent company
168.67%8.52M
12.44%-11.69M
3.38%-52.34M
-33.18%-15.32M
5.98%-11.25M
14.95%-12.41M
17.08%-13.36M
-144.10%-54.17M
55.75%-11.5M
-5.13%-11.97M
Preferred stock dividends
Other preferred stock dividends
150K
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
167.46%8.37M
12.44%-11.69M
3.38%-52.34M
-33.18%-15.32M
5.98%-11.25M
14.95%-12.41M
17.08%-13.36M
-145.20%-54.17M
54.26%-11.5M
-5.13%-11.97M
Basic earnings per share
166.67%0.12
10.53%-0.17
3.90%-0.74
-37.50%-0.22
5.88%-0.16
14.29%-0.18
17.39%-0.19
-143.26%-0.77
57.89%-0.16
0.00%-0.17
Diluted earnings per share
166.67%0.12
10.53%-0.17
3.90%-0.74
-37.50%-0.22
5.88%-0.16
14.29%-0.18
17.39%-0.19
-143.75%-0.77
57.89%-0.16
0.00%-0.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 125.33%169K124.24%148K-73.93%391.7K205.88%141.56K881.55%108.97K75K-95.43%66K-99.28%1.5M46.28K11.1K
Operating revenue 125.33%169K124.24%148K-73.93%391.7K205.88%141.56K881.55%108.97K--75K-95.43%66K-99.28%1.5M--46.28K--11.1K
Cost of revenue
Gross profit
Operating expense 45.20%20.69M17.43%17.57M4.60%59.67M50.02%18.33M-5.29%12.14M-0.40%14.25M-15.55%14.96M-32.22%57.05M-53.63%12.22M9.71%12.82M
Selling and administrative expenses -1.75%8.1M-14.08%7.17M-4.15%31.09M15.40%7.69M-10.84%6.81M-0.11%8.25M-15.56%8.34M-12.89%32.43M-19.36%6.66M12.83%7.63M
-General and administrative expense -1.75%8.1M-14.08%7.17M-4.15%31.09M15.40%7.69M-10.84%6.81M-0.11%8.25M-15.56%8.34M-12.89%32.43M-19.36%6.66M12.83%7.63M
Research and development costs 109.73%12.58M57.17%10.4M16.12%28.59M91.53%10.64M2.88%5.33M-0.79%6M-15.54%6.62M-47.55%24.62M-69.29%5.56M5.41%5.18M
Operating profit -44.77%-20.52M-16.96%-17.42M-6.72%-59.28M-49.42%-18.19M6.06%-12.03M0.92%-14.17M8.45%-14.89M-144.72%-55.55M53.81%-12.17M-9.61%-12.8M
Net non-operating interest income expense 4.9M
Non-operating interest income ----------4.9M----------------------------
Other net income (expense) 1,546.15%29.04M272.59%5.72M45.02%2M-410.75%-2.08M-7.13%776.45K720.85%1.76M634.75%1.54M3,118.45%1.38M17,018.19%668.12K31,367.26%836.09K
Gain on sale of security ----------2M----------------------------
Other non- operating income (expenses) 1,546.15%29.04M272.59%5.72M---------7.13%776.45K720.85%1.76M634.75%1.54M3,118.45%1.38M17,018.19%668.12K31,367.26%836.09K
Income before tax 168.67%8.52M12.44%-11.69M3.38%-52.34M-33.18%-15.32M5.98%-11.25M14.95%-12.41M16.83%-13.36M-143.63%-54.17M56.34%-11.5M-2.47%-11.97M
Income tax 0000000000
Net income 168.67%8.52M12.44%-11.69M3.38%-52.34M-33.18%-15.32M5.98%-11.25M14.95%-12.41M17.08%-13.36M-144.10%-54.17M55.75%-11.5M-5.13%-11.97M
Net income continuous Operations 168.67%8.52M12.44%-11.69M3.38%-52.34M-33.18%-15.32M5.98%-11.25M14.95%-12.41M17.08%-13.36M-144.10%-54.17M55.75%-11.5M-5.13%-11.97M
Minority interest income
Net income attributable to the parent company 168.67%8.52M12.44%-11.69M3.38%-52.34M-33.18%-15.32M5.98%-11.25M14.95%-12.41M17.08%-13.36M-144.10%-54.17M55.75%-11.5M-5.13%-11.97M
Preferred stock dividends
Other preferred stock dividends 150K000000000
Net income attributable to common stockholders 167.46%8.37M12.44%-11.69M3.38%-52.34M-33.18%-15.32M5.98%-11.25M14.95%-12.41M17.08%-13.36M-145.20%-54.17M54.26%-11.5M-5.13%-11.97M
Basic earnings per share 166.67%0.1210.53%-0.173.90%-0.74-37.50%-0.225.88%-0.1614.29%-0.1817.39%-0.19-143.26%-0.7757.89%-0.160.00%-0.17
Diluted earnings per share 166.67%0.1210.53%-0.173.90%-0.74-37.50%-0.225.88%-0.1614.29%-0.1817.39%-0.19-143.75%-0.7757.89%-0.160.00%-0.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data